Elevated ERβ expression in bladder cancers was also found to correlate with higher risks of tumor recurrence and/or progression [30, 40, 57], and ERβ positivity was an independent predictor of tumor progression [30]. This evidence concerns the gene ESR2 and urinary bladder carcinoma.